Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 74

1.

Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men.

Plourde M, Vohl MC, Vandal M, Couture P, Lemieux S, Cunnane SC.

Br J Nutr. 2009 Oct;102(8):1121-4. doi: 10.1017/S000711450938215X.

PMID:
19828088
2.

Thyroid Function and Cognition during Aging.

Bégin ME, Langlois MF, Lorrain D, Cunnane SC.

Curr Gerontol Geriatr Res. 2008:474868. doi: 10.1155/2008/474868. Epub 2008 Sep 1.

3.

Plasma omega-3 fatty acid response to a fish oil supplement in the healthy elderly.

Vandal M, Freemantle E, Tremblay-Mercier J, Plourde M, Fortier M, Bruneau J, Gagnon J, Bégin M, Cunnane SC.

Lipids. 2008 Nov;43(11):1085-9. doi: 10.1007/s11745-008-3232-z. Epub 2008 Sep 16.

PMID:
18795357
4.
5.

Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver.

Rapoport SI, Rao JS, Igarashi M.

Prostaglandins Leukot Essent Fatty Acids. 2007 Nov-Dec;77(5-6):251-61. Epub 2007 Dec 3.

6.

Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.

Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D.

Arch Gen Psychiatry. 2007 Dec;64(12):1443-50.

7.

Unresolved issues in the link between docosahexaenoic acid and Alzheimer's disease.

Plourde M, Fortier M, Vandal M, Tremblay-Mercier J, Freemantle E, Bégin M, Pifferi F, Cunnane SC.

Prostaglandins Leukot Essent Fatty Acids. 2007 Nov-Dec;77(5-6):301-8. Epub 2007 Nov 26. Review.

PMID:
18036804
8.

Dietary patterns and risk of dementia: the Three-City cohort study.

Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, Alpérovitch A.

Neurology. 2007 Nov 13;69(20):1921-30.

PMID:
17998483
9.

n 3 fatty acid proportions in plasma and cognitive performance in older adults.

Dullemeijer C, Durga J, Brouwer IA, van de Rest O, Kok FJ, Brummer RJ, van Boxtel MP, Verhoef P.

Am J Clin Nutr. 2007 Nov;86(5):1479-85.

10.

Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study.

Nurk E, Drevon CA, Refsum H, Solvoll K, Vollset SE, Nygård O, Nygaard HA, Engedal K, Tell GS, Smith AD.

Am J Clin Nutr. 2007 Nov;86(5):1470-8.

11.

Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study.

Cherubini A, Andres-Lacueva C, Martin A, Lauretani F, Iorio AD, Bartali B, Corsi A, Bandinelli S, Mattson MP, Ferrucci L.

J Gerontol A Biol Sci Med Sci. 2007 Oct;62(10):1120-6.

12.

n-3 Fatty acids, hypertension and risk of cognitive decline among older adults in the Atherosclerosis Risk in Communities (ARIC) study.

Beydoun MA, Kaufman JS, Sloane PD, Heiss G, Ibrahim J.

Public Health Nutr. 2008 Jan;11(1):17-29. Epub 2007 Jul 12.

13.

Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements.

Plourde M, Cunnane SC.

Appl Physiol Nutr Metab. 2007 Aug;32(4):619-34. Review. Erratum in: Appl Physiol Nutr Metab. 2008 Feb;33(1):228-9.

PMID:
17622276
14.

IANA task force on nutrition and cognitive decline with aging.

Gillette Guyonnet S, Abellan Van Kan G, Andrieu S, Barberger Gateau P, Berr C, Bonnefoy M, Dartigues JF, de Groot L, Ferry M, Galan P, Hercberg S, Jeandel C, Morris MC, Nourhashemi F, Payette H, Poulain JP, Portet F, Roussel AM, Ritz P, Rolland Y, Vellas B.

J Nutr Health Aging. 2007 Mar-Apr;11(2):132-52. Review.

PMID:
17435956
15.

Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study.

van Gelder BM, Tijhuis M, Kalmijn S, Kromhout D.

Am J Clin Nutr. 2007 Apr;85(4):1142-7.

16.

Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study.

Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR.

Am J Clin Nutr. 2007 Apr;85(4):1103-11.

17.

APOE genotype and cognitive functioning in a large age-stratified population sample.

Jorm AF, Mather KA, Butterworth P, Anstey KJ, Christensen H, Easteal S.

Neuropsychology. 2007 Jan;21(1):1-8.

PMID:
17201525
18.

Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.

Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA.

Arch Neurol. 2006 Nov;63(11):1545-50.

PMID:
17101822
19.

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J.

Arch Neurol. 2006 Oct;63(10):1402-8.

PMID:
17030655
20.

Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction.

Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, Kiso Y, Sakakibara M, Yoshimoto T, Guo J, Yamashima T.

Neurosci Res. 2006 Oct;56(2):159-64. Epub 2006 Aug 14.

PMID:
16905216

Supplemental Content

Support Center